To MediSwipe Shareholders:
I am pleased to update the investment community and other interested parties on the progress to date of MediSwipe Inc. and our corporate strategy as we move forward into 2012. We have been working closely with all our strategic partners and clients to advance the interests of the Company on behalf of our shareholders. As you are aware, near the
end of 2011, there were numerous events on both the legislative and banking side within the medicinal and alternative health sector that caused us to modify our business model and seek vertical markets to remain a viable company. It takes more than six months to build a solid business model within a sector subject to monthly legislative changes.
I have always believed the company offers industry changing technology , and the time is now ripe for our industry to embrace our functionality through the solutions and partnerships we have built within the healthcare and payment industries. I continue to be impressed by the clear advantage in functionality that the MediSwipe solutions have over
any competing solution in the financial payments market, and our strategy of building partnerships with industry leaders will soon begin to yield meaningful revenue results. In addition, we have expanded our relationships with our existing client base significantly in late 2011 and early 2012 and anticipate our revenue will increase markedly as a
result of these efforts. We expect that all of our activities last year will combine to deliver greatly improved results in 2012.
With regard to the pending S-1 registration of our division 800 Commerce, while it was the intentions of management to complete this registration before year end, we were delayed by proposed acquisitions as part of the filing, and a last decision by our independent auditing firm to include December 2011 financials as part of the filing for two years completed financials. Although disappointing, it is typical in for negotiations and such comprehensive auditing reports to continue beyond the deadlines in order to reach mutually acceptable and workable resolutions. Regardless, MWIP has now completed the two year financial reports for 800 commerce, submitted them to our auditor, and the filing
is forthcoming as promised. The 8-K filing was not necessary as we had not changed primary auditors, simply added an additional firm for the 800 Commerce audits. We have been approved and received a CUSIP number for the Spin-off to issue certificates to our shareholders once effective, and will file the form 15C-211 simultaneously for a separate
symbol with the S-1 filing. We will keep shareholders updated in a timely manner once the filing date is reached.
Sales
Our merchant processing volume has remained constant, despite what has happened within the medicinal sector in California and Colorado. With the recent breakthrough in Arizona, we expect to attack the area aggressively with our payment card solution, as MediSwipe was featured as the major technology partner in the Arizona Business Journal last
year as a primary financial partner for the industry.
Technology
Our new mobile payment, gift and loyalty solution through technology partners will prove to be a major revenue source throughout 2012 as an alternative payment solution, not only within the healthcare sector, but to small business as well with its’ mobile coupon, gift and SMS offering features.
Partnerships
We have signed several new agreements with details to be announced over the next few weeks that will grow our company within the healthcare sector beyond payment solutions and utilize our network of pharmacies and wellness centers, including private labeled nutraceutical product lines and online sales of existing products through our 800 Commerce e-shopping cart systems. World demand for nutraceutical ingredients is projected to increase more than 7% percent annually to nearly $24 billion in 2015.
Additionally, on the 800 Commerce side, we have signed agreements for SMS messaging technologies and IVR technology that will enable us to become a major competitor in the mobile health space for medical alerts
and bill pay. Details on these agreements will be released in the next short weeks.
We also plan to continue our aggressive acquisition campaign, and believe that we have targeted our potential partner which will take the place of our initial VestaDigital plan, that will allow us to pursue the social media component of healthcare, which we believe will prove to be a very important aspect of the future of healthcare.
If you have questions, please ask the Company directly through its investor relations representative, 615.252.4099 ext. 103. Merchants interested in more information on the merchant processing, mobile payment and the nutraceutical line for their business should contact the Company at 615.252.4099 ext. 101
“We would like to thank our shareholders for their continued patience and appreciate the confidence you have extended to the company.”
Respectfully,
B. Michael Friedman
To MediSwipe Shareholders: I am pleased to update the
Top 10 Most Recent News Articles
EPR Fireworks, Schedule2.IT Enhance EMS Integration
Joining Forces for Effective EMS Management In a move that could shake up emergency medical services, EPR Fireworks has teamed up with Schedule2.IT to amp up integration. This Florida-based partnership is all about breaking down those bureaucratic firewalls between patient care and controlled substances tracking. They’re pushing for a seamless workflow, where crucial...
Continue Reading
Concrete Pipe: Foundation of Modern Infrastructure
Reinforced Concrete Pipes Hold Their Ground You know, it might not be the flashiest part of our infrastructure toolkit, but concrete pipe plays a mighty big role behind the scenes. Even in this age of shiny new tech and constantly evolving materials, the classic concrete pipe still packs a punch—especially when you demand something that'll last. Enter Stephanie Ward, a...
Continue Reading
Superga and Pasqua's Unlikely Fashion-Vineyard Fusion
Superga and Pasqua: A Fusion of Fashion and Vineyards Here's one for the books: Superga, the storied Italian footwear maestro, teaming up with Pasqua Wines, straight out of Verona’s vineyard heartland. On the surface, it seems a rather odd coupling. One's got rubber soles; the other’s got corks. But they’ve pulled off a daring bedroom switch, creating a...
Continue Reading
Comparent Unveils Key Insights with Top 100 List
The Ebb and Flow of Vacation Rental Giants Ever noticed how some industries just sneak up and suddenly transform landscapes? Vacation rental management is one of those sneaky offenders. At the forefront of keeping tabs on this bustling sector, Comparent just dropped a meaty second annual roster—the Comparent 100—showcasing the biggest players flexing their muscles in...
Continue Reading
Hyundai's Record Q3 Sales: SUVs and Hybrids Lead
Hyundai's Drive to Record Q3 Sales When talking about market moves, Hyundai's recent figures speak louder than most quarterly bells. September 2026 marked a whirlwind of growth for Hyundai Motor America, reporting record-breaking sales numbers not just for the month, but for Q3 as a whole. With a 9% jump from September last year in total vehicle sales and a remarkable 3%...
Continue Reading
FSS Unveils AI Tool to Simplify Bankruptcy Cases
AI Revolution in Bankruptcy Management Alright, folks, there's a fresh breeze blowing in the bankruptcy management world, and it bears the acronym FSS. Financial Software Solutions is rolling out its innovative FSS Intelligence Engine. This little powerhouse aims to turn what used to be a gut-wrenching slog through mountains of paperwork into a slick, automated process....
Continue Reading
Vortex Expands UK Reach with Torrent Acquisition Boost
Vortex's Ambitious UK Expansion A seasoned investor keen on infrastructure plays would find Vortex Companies’ latest move significant—not just another acquisition, but a realigned strategy for dominance as Britain braces for an infrastructure overhaul. With Torrent Drainage Services in their pocket, the Vortex Group plans to amp up its trenchless rehabilitation...
Continue Reading
Gateway Unveils All-In-One Award Travel Platform
Transforming Loyalty with point.me's Gateway Here's the deal: the loyalty program game just changed. Point.me rolled out this slick beast called Gateway, and it's weaving award travel booking right into your everyday banking apps. That's right, ditch those clunky third-party sites, because now you can browse, compare, transfer, and book your award travel directly from...
Continue Reading
Haystack MRD Shines in Colorectal Cancer Trials
A New Dawn in Cancer Detection Just when you think you've seen it all in cancer diagnostics, Haystack MRD® pops up like a fresh tulip in spring. And listen, this ain't just fluff—the results from the DYNAMIC trials are a pretty compelling love letter to the power of liquid biopsy. With 100% specificity and sensitivity hitting a whopping 83.3% over five years, it’s...
Continue Reading
Medicare Payment Proposal Faces Doctor Backlash in D.C.
Why Same-Day Medicare Care Matters Imagine you're gasping for breath, struggling to find relief, and then being told to wait weeks for care. It's not just an inconvenience; it's a health hazard. This isn't some arbitrary tale—it's the gritty reality for folks relying on same-day care. A group of docs and advocates recently stormed Capitol Hill sounding the alarm about a...
Continue ReadingTop 5 Most Recently Viewed Articles
Important Details for Alarum Technologies Ltd. Investors
Understanding Your Rights as an Alarum Technologies Investor Investors in Alarum Technologies Ltd. (NASDAQ: ALAR) are encouraged to connect with Levi & Korsinsky, LLP to understand their rights in relation to a recent class action securities lawsuit. This lawsuit has been initiated to protect the interests of investors who may have suffered losses due to alleged...
Continue Reading
Humacyte, Inc. Investors Urged to Act Before Class Action Deadline
Important Attention for Humacyte, Inc. Investors As an investor in Humacyte, Inc., it’s essential to stay informed about legal opportunities that could impact your investments. The Rosen Law Firm, known for its dedication to protecting investor rights, is reminding those who purchased Humacyte securities during a specified period about an important upcoming deadline....
Continue Reading
RSI Stock Reaches New Heights with 273% Annual Growth Insights
RSI Stock Surges to New Heights In the world of stock performance, few stories shine as brightly as that of dMY Technology Group, Inc. (RSI). Recently, the company's shares soared to a remarkable 52-week high, reaching $14.93. This significant milestone reflects a promising upward trend, affirming the company’s $3.36 billion market cap. Investors closely eye these...
Continue Reading
Bioretec's Innovative Strategy for Enhanced Orthopedic Care
Bioretec Updates Strategy for Future Growth Bioretec Ltd recently announced an exciting update regarding its strategic direction covering 2026 to 2028. This plan emerges from a thorough evaluation process aimed at enhancing commercialization efforts and expanding the company's product offerings in the orthopedic device sector. Overview of Bioretec's New Strategy...
Continue Reading
Prochant Unveils Engagement Services to Transform RCM Efficiency
Prochant Introduces Innovative Engagement Services for RCM Prochant, a leader in revenue cycle management (RCM) solutions for the home-based care industry, is thrilled to unveil its latest offering: Engagement Services. This innovative approach aims to optimize communication between healthcare providers and their patients, alongside referral sources such as hospitals and...
Continue Reading